natgillin/translations-raw huggingface dataset:
For the full list of all side effects reported with Velosulin, see the Package Leaflet.
Celovit opis neželenih učinkov, o katerih so poročali pri uporabi zdravila Velosulin, najdete v Navodilih za uporabo.
What is Velosulin used for?
Za kaj se zdravilo Velosulin uporablja?
What is Velosulin?
Kaj je zdravilo Velosulin?
How has Velosulin been studied?
Kako je bilo zdravilo Velosulin raziskano?
Velosulin doses might also need to be adjusted when given with a number of other medicines which may have an effect on blood glucose.
Odmerke zdravila Velosulin bo morda potrebno prilagoditi, če se zdravilo jemlje istočasno z drugimi zdravili, ki lahko vplivajo na koncentracijo sladkorja v krvi (celoten seznam le-teh najdete v Navodilih za uporabo).
How does Velosulin work?
Kako zdravilo Velosulin deluje?
The active substance in Velosulin, insulin human (rDNA), is produced by a method known as ‘recombinant DNA technology': the insulin is made by a yeast that has received a gene (DNA), which makes it able to produce insulin.
Zdravilna učinkovina zdravila Velosulin je humani insulin (rDNA), izdelan z metodo, imenovano „rekombinantna tehnologija“.
How is Velosulin used?
Kako se zdravilo Velosulin uporablja?
Velosulin is a solution for injection or infusion (drip).
Velosulin je bistra, brezbarvna raztopina insulina za injiciranje ali infundiranje v viali.
They should both have the same colour.
Oba morata biti iste barve.
Date of first authorisation: 16 September 2003 Date of latest renewal: 26 August 2013
Datum prve odobritve: 16. september 2003 Datum zadnjega podaljšanja: 26. avgust 2013
* Life-threatening and/or fatal cases have been reported.
* Poročali so o življenjsko ogrožajočih in/ali smrtnih primerih.
Do not drive or operate any tools or machines if you feel these effects.
Ne vozite in ne upravljajte orodij ali strojev, če občutite te učinke.
A specific antidote is not known.
Specifični antidot ni znan.
Do not use a facial mask.
Ne uporabljajte maske za obraz.
This dose should be maintained.
Ta odmerek je treba vzdrževati.
Tell your doctor if you are taking:
Obvestite zdravnika, če jemljete:
Your blood pressure may drop much further.
Vaš krvni tlak se lahko še dodatno zniža.
If it does, rinse the skin or your eyes immediately with plenty of water.
Če se to zgodi, kožo ali oči takoj sperite z večjo količino vode.
No unchanged substance is eliminated.
nespremenjeni obliki se ne izloča.
The following information is intended for healthcare professionals only: Instructions for use and handling
Naslednje informacije so namenjene samo zdravstvenemu osebju: Navodila za pripravo in ravnanje z zdravilom
Tell your doctor if they get worse.
Obvestite zdravnika, če se stanje poslabša.
System organ class (MedDRA)
Organski sistem (MedDRA)
Two programmes can be operated:
Na voljo sta dva programa:
In this case talk to your doctor immediately.
V tem primeru se takoj posvetujte z zdravnikom.
No data from controlled clinical trials are available.
Na voljo ni podatkov iz nadzorovanih kliničnih preskušanj.
Component of a multipack, can't be sold separately.
Sestavni deli večkratnega pakiranja se ne morejo prodajati ločeno.
The duration of treatment depends on clinical status and is left to the physician's discretion.
Trajanje zdravljenja je odvisno od kliničnega stanja in je prepuščeno presoji zdravnika.
These concentrations decline with half-lives between approximately 5 and 25 minutes.
Te koncentracije padajo z razpolovnim časom približno 5 do 25 minut.
Your doctor will monitor you carefully.
Zdravnik vas bo skrbno spremljal.
Elderly Pharmacokinetics in elderly patients have not been investigated.
Farmakokinetike pri starejših bolnikih niso preučevali.
In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.
Zaradi pomanjkanja študij kompatibilnosti zdravila se ga ne sme mešati z drugimi zdravili.
He/she will look for the cause and take appropriate measures.
Pregledal vas bo, da bi ugotovil vzroke težav in ustrezno ukrepal.
PPH is a category of pulmonary hypertension where the cause of the high blood pressure is not known.
PPH je kategorija pljučne hipertenzije, pri kateri vzrok visokega krvnega tlaka ni znan.
Do not use this medicine after the expiry date which is stated on the carton and ampoule.
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in ampuli.
The safety and efficacy of Ventavis in children aged up to 18 years have not been established.
Varnost in učinkovitost zdravila Ventavis pri otrocih, starih do 18 let, nista bili dokazani.
Your doctor will monitor you and treat any resulting symptoms.
Zdravnik vas bo spremljal in zdravil morebitne simptome.
Bayer Austria Ges.
Österreich Bayer Austria Ges.
Stand up slowly when you get out of chairs or bed.
S stola ali iz postelje vstajajte počasi.
The active substance can be delivered more rapidly to your lungs.
Učinkovina se lahko hitreje dovede v vaša pljuča.
When using the I-Neb AAD system the following instructions need to be followed.
Pri uporabi nebulatorja I-Neb AAD je treba slediti naslednjim navodilom.
You should continue on this dose.
Nadaljevati morate s tem odmerkom.
Not known (cannot be estimated from the available data)
neznana (ni mogoče oceniti iz razpoložljivih podatkov)
If you tend to faint as soon as you get out of bed, it may be helpful to take your first dose of the day while you are still lying down.
Če ste nagnjeni k omedlevicam, takoj ko vstanete iz postelje, vam bo morda pomagalo, če vzamete svoj prvi dnevni odmerek, ko še ležite.
Ventavis and certain other medicines may affect each other in the way they work in your body.
Zdravilo Ventavis in nekatera druga zdravila lahko v vašem telesu vplivajo druga na drugo.
No reliable conclusion could be drawn on efficacy of the association as the sample size was limited and the study was of short duration.
Zanesljivih zaključkov glede učinkovitosti ni, ker je bil vzorec premajhen in je preskušanje trajalo prekratek čas.
Ventavis with food and drink
Zdravilo Ventavis skupaj s hrano in pijačo
• Fainting episodes may be due to the underlying disease.
• Pogoste omedlevice so lahko posledica osnovne bolezni.
To avoid undesired accumulation over the day, special caution has to be exercised with these patients during initial dose titration.
Da bi se izognili neželenemu kopičenju zdravila tekom dneva, je pri teh bolnikih potrebna posebna previdnost pri titraciji začetnega odmerka.
If you feel that the effect of Ventavis is too strong or too weak, talk to your doctor or pharmacist.
Če menite, da je učinek zdravila Ventavis premočan ali prešibak, se posvetujte z zdravnikom ali farmacevtom.
• The active substance is iloprost.
• Učinkovina je iloprost.
The following serious side effects may occur.
Pojavijo se lahko naslednji resni neželeni učinki.
§ see section “Description of selected adverse reactions”
§ glejte poglavje »Opis izbranih neželenih učinkov«
Cases of overdose were reported.
Simptomi Poročali so o primerih prevelikega odmerjanja.
However, the predictive value of these acute haemodynamic data are considered to be of limited value as acute response does not in all cases correlate with long-term benefit of treatment with inhaled iloprost.
Kljub temu pa je napovedna vrednost teh akutnih hemodinamičnih podatkov omejena, ker akutni odziv v vseh primerih ni sorazmeren z dolgoročno koristnostjo zdravljenja z inhalacijami iloprosta.
Multipacks containing:
Večkratno pakiranje vsebuje:
Improved blood flow leads to a better supply of oxygen to the body and reduced strain on the heart.
Izboljšan pretok krvi povzroči boljšo oskrbo telesa s kisikom in zmanjšano obremenitev srca.
There are two different colour coded medication chambers.
Obstajata dva z različnima barvama označena prostora za zdravilo.
Pharmacokinetics after use with different nebulisers
Farmakokinetika pri uporabi različnih nebulatorjev
The frequencies of adverse reactions are defined as very common (≥1/10) and common (≥1/100 to <1/10).
Pogostnost neželenih učinkov je opredeljena kot zelo pogosti (≥ 1/10) in pogosti (≥ 1/100 do < 1/10).
Interruption of the inhalation session, monitoring and symptomatic measures are recommended.
Priporoča se prekinitev inhalacije, spremljanje in simptomatsko zdravljenje.
The main metabolite is tetranor-iloprost, which is found in the urine in free and conjugated form.
Glavni presnovek je tetranor-iloprost, ki se v seču nahaja v prosti in konjugirani obliki.
• anticoagulants, such as heparin, oral anticoagulants (either coumarin-type or direct),
• antikoagulanti, kot so heparin, peroralni antikoagulanti (bodisi kumarini ali neposredni antikoagulanti),
If you swallow it accidentally, drink plenty of water and tell your doctor.
Če bi jo po nesreči popili, spijte večjo količino vode in se posvetujte z zdravnikom.
Not known: frequency cannot be estimated from the available data.
Neznana: pogostnosti ni mogoče oceniti iz razpoložljivih podatkov
Ventavis should not be initiated in patients with systolic blood pressure less than 85 mmHg.
Zdravila Ventavis se ne sme uvesti pri bolnikih s sistoličnim krvnim tlakom, nižjim od 85 mmHg.
• if you are allergic to iloprost or any of the other ingredients of this medicine (listed in section 6),
• če ste alergični na iloprost ali katero koli sestavino tega zdravila (navedeno v poglavju 6),
The adverse reactions identified only during post-marketing surveillance, and for which a frequency could not be estimated from clinical trial data, are listed under "Frequency not known".
Neželeni učinki, ugotovljeni samo v obdobju trženja in za katere pogostnosti ni mogoče oceniti na podlagi podatkov iz kliničnih preskušanj, so navedeni kot »neznana«.
The acute adverse effects in patients receiving concomitant bosentan and iloprost were consistent with those observed in the larger experience of the phase 3 study in patients receiving only iloprost.
Akutni neželeni učinki pri bolnikih, ki so sočasno prejemali bosentan in iloprost, so bili enaki tistim, ki so jih opazili v večji študiji III. faze pri bolnikih, ki so prejemali samo iloprost.
In clinical trials peripheral oedema was reported in 12.2% of patients on iloprost and 16.2% of patients on placebo.
V kliničnih preskušanjih so poročali o perifernem edemu pri 12,2 % bolnikov, ki so prejemali iloprost, in pri 16,2 % bolnikov, ki so prejemali placebo.
Invasive haemodynamic parameters were assessed at baseline and after 12 weeks treatment.
Invazivni hemodinamični dejavniki so bili ocenjeni na začetku in po 12 tednih zdravljenja.
Ventavis is used to improve exercise capacity (the ability to carry out physical activity) and symptoms.
Zdravilo Ventavis se uporablja za izboljšanje telesnih sposobnosti (zmožnosti opravljanja fizičnih aktivnosti) in lajšanje simptomov.
Control disc
Nadzorni disk
Use dosing intervals of 3 - 4 hours (this corresponds to a maximum of 6 administrations per day).
Interval med posameznimi odmerki naj bo 3 - 4 ure (to ustreza največ 6 aplikacijam na dan).
A mass-balance study was done using 3H-iloprost in healthy subjects.
Študija masnega ravnovesja je bila opravljena pri zdravih osebah s pomočjo 3H-iloprosta.
Ventavis should only be used during pregnancy if your doctor decides that the potential benefit outweighs the potential risk to you and the foetus.
Zdravilo Ventavis se sme uporabljati med nosečnostjo le, če zdravnik presodi, da so možne koristi večje od možnega tveganja za vas in plod.
Patients with a creatinine clearance of ≤30 ml/min were not investigated in the clinical trials.
Bolniki z očistkom kreatinina ≤ 30 ml/min niso bili vključeni v klinična preskušanja.
Animal studies have not shown harmful effect of iloprost on fertility.
Študije na živalih ne kažejo škodljivih učinkov iloprosta na plodnost.
Patients with concomitant acute pulmonary infections, COPD and severe asthma should be carefully monitored.
Bolnike s sočasnimi akutnimi pljučnimi okužbami, KOPB in hudo astmo je treba skrbno spremljati.
Stop using Ventavis and tell your doctor immediately.
Prenehajte uporabljati zdravilo Ventavis in takoj obvestite zdravnika.
Other medicines and Ventavis
Druga zdravila in zdravilo Ventavis
In comparable embryotoxicity studies in rabbits and monkeys no such digit anomalies or other gross-structural anomalies were observed even after considerably higher dose levels which exceeded the human dose multiple times.
V primerljivih študijah embriotoksičnosti pri kuncih in opicah takih anomalij prstov ali drugih večjih strukturnih anomalij niso opazili, niti pri znatno večjih odmerkih, ki so večkrat presegli odmerke pri človeku.
Symptoms of overdoses are mainly related to the vasodilatory effect of iloprost.
Simptomi prevelikega odmerjanja so v glavnem povezani z vazodilatornim učinkom iloprosta.
• if you have had a stroke within the last 3 months, or any other occurrence that reduced the blood supply to the brain (e.g. transient ischaemic attack),
• če ste v zadnjih 3 mesecih imeli možgansko kap ali kakšno drugo stanje, ki zmanjša preskrbo možganov s krvjo (npr. tranzitorna ishemična ataka),
Treatment of adult patients with primary pulmonary hypertension, classified as NYHA functional class III, to improve exercise capacity and symptoms.
Zdravljenje odraslih bolnikov s primarno pljučno hipertenzijo, opredeljeno kot III. funkcijski razred po klasifikaciji NYHA, za izboljšanje telesne zmogljivosti in lajšanje simptomov.
Women with pulmonary hypertension (PH) should avoid pregnancy as it may lead to life-threatening exacerbation of the disease.
Ženske s pljučno hipertenzijo (PH - pulmonary hypertension) bi se morale izogibati nosečnosti, ker lahko pride do življenjsko ogrožajočega poslabšanja bolezni.
The mean daily inhaled dose was 27 microgram and the mean number of inhalations per day was 5.6.
Povprečni dnevni inhalirani odmerek je bil 27 mikrogramov, povprečno število inhalacij na dan pa 5,6.
Total plasma protein binding of iloprost is concentration-independent in the range of 30 to 3,000 picogram/ml and amounts to approximately 60%, of which 75% is due to albumin binding.
Celokupna vezava iloprosta na beljakovine v plazmi je neodvisna od koncentracije v mejah od 30 do 3.000 pikogramov/ml in znaša približno 60 %; od tega 75 % predstavlja vezavo na albumin.
There is a limited amount of data from the use of iloprost in pregnant women.
Podatkov o uporabi iloprosta pri nosečnicah je malo.
He/she may consider adjusting your dose or changing your treatment.
Morda se bo odločil za prilagoditev odmerka ali spremembo zdravljenja.
• If you are pregnant, think you might be or are planning to have a baby, tell your doctor straight away.
• Če ste noseči ali dojite, menite, da ste noseči ali načrtujete zanositev, o tem takoj obvestite zdravnika.
Most people will have 6 to 9 inhalation sessions spread throughout the day.
Pri večini ljudi zadostuje 6 do 9 inhalacij na dan, razporejenih preko celega dneva.
The rate of responders to iloprost was 16.8% (17/101) and the rate of responders in the placebo group was 4.9% (5/102) (p=0.007).
Delež tistih, ki so se odzvali na iloprost, je bil 16,8 % (17/101), delež odzivov v placebo skupini pa 4,9 % (5/102) (p = 0,007).
If a pregnancy occurs, taking into account the potential maternal benefit, the use of Ventavis during pregnancy may be considered, only following careful benefit-risk evaluation, in those women who choose to continue their pregnancy, despite the known risks of pulmonary hypertension during pregnancy.
Če ženska zanosi, je treba upoštevati možne koristi za mater, ker se zdravilo Ventavis lahko uporablja med nosečnostjo le po skrbni oceni koristi in tveganj pri tistih ženskah, ki se odločijo za nadaljevanje nosečnosti kljub znanim tveganjem za pljučno hipertenzijo med nosečnostjo.
• If you could get pregnant, use reliable contraception from the time you start treatment and during treatment.
• Če je možno, da bi lahko zanosili, potem od takrat ko začnete zdravljenje in med zdravljenjem uporabljajte učinkovito kontracepcijsko metodo.
In the iloprost group the NYHA class was improved in 26% of patients (placebo: 15%) (p = 0.032), unchanged in 67.7% of patients (placebo: 76%) and deteriorated in 6.3% of patients (placebo: 9%).
V skupini z iloprostom se je razred po klasifikaciji NYHA izboljšal pri 26 % bolnikov (placebo 15 %) (p = 0,032), ostal nespremenjen pri 67,7 % bolnikov (placebo 76 %) in se poslabšal pri 6,3 % bolnikov
Considering the high pharmacological potency of iloprost and the absolute doses required for therapeutic purposes the results obtained in acute toxicity studies do not indicate a risk of acute adverse effects in humans.
Ob upoštevanju visoke farmakološke učinkovitosti iloprosta ter absolutnih odmerkov, ki so potrebni za doseganje učinkov zdravljenja, izsledki študij akutne toksičnosti ne kažejo, da bi pri človeku obstajalo tveganje za pojav akutnih neželenih učinkov.
Animal studies have shown reproductive effects (see section 5.3).
Študije na živalih so pokazale vpliv na sposobnost razmnoževanja (glejte poglavje 5.3).
Your doctor will adjust Venta-Neb to the programme you need to receive the dose prescribed for you.
Zdravnik vam bo nastavil Venta-Neb na program, s katerim boste lahko prejeli predpisani odmerek.
Tell your doctor if you have a lung infection, severe asthma, or chronic lung disease (chronic obstructive pulmonary disease).
Zdravnika obvestite, če imate okužbo pljuč, hudo astmo ali kronično pljučno obolenje (kronično obstruktivno pljučno bolezen).
Suitable inhalation device (nebuliser) to be used
Ustrezen pripomoček za inhaliranje (nebulator), ki ga je treba uporabiti
Results of in vitro studies reveal that CYP 450-dependent metabolism plays only a minor role in the biotransformation of iloprost.
Izsledki in vitro študij kažejo, da ima od CYP 450 odvisna presnova le manjšo vlogo v biotransformaciji iloprosta.
Gender Gender is not of clinical relevance to the pharmacokinetics of iloprost.
Spol ne vpliva klinično pomembno na farmakokinetiko iloprosta.
• If you suffer from a weak heart condition such as right heart failure, and feel that your disease is worsening, tell your doctor.
• Če imate oslabljeno srce, npr. desnostransko srčno popuščanje in imate občutek, da se je bolezen poslabšala, obvestite zdravnika.
• Do NOT let Ventavis solution come into contact with your skin or eyes.
• Pazite, da zdravilo Ventavis NE pride v stik s kožo ali očmi.
Depending on your individual needs, Ventavis can be used for long term treatment.
Glede na vaše potrebe se zdravilo Ventavis lahko uporablja za dolgotrajno zdravljenje.
The most frequently observed adverse reactions (≥ 20 %) in clinical trials include vasodilatation (including hypotension), headache and cough.
Najpogostejši neželeni učinki (≥ 20 %), ki so jih opazili v kliničnih preskušanjih, so vazodilatacija (vključno s hipotenzijo), glavobol in kašelj.
• Dilatation of arterioles and venules
• razširitev arteriol in venul,
This medicinal product contains small amounts of ethanol (alcohol), less than 100 mg per dose.
To zdravilo vsebuje majhne količine etanola (alkohola), in sicer manj kot 100 mg na odmerek.
First dosing with 2.5 microgram should be done even if patients had already been stable on 5 microgram inhaled with an alternative device (see section 4.2).
Prvo odmerjanje z 2,5 mikrograma je treba narediti tudi, če so bili bolniki stabilni že pri odmerku 5 mikrogramov, inhaliranim z drugim pripomočkom (glejte poglavje 4.2).
Estimated inhalation time
Predviden inhalacijski čas
Ventavis contains ethanol
Zdravilo Ventavis vsebuje etanol
Symptoms can be flushing or reddening of the face.
Simptoma sta lahko pordelost ali pordevanje obraza.
Pulmonary vasodilators may significantly worsen the cardiovascular status of patients with pulmonary veno-occlusive disease.
Pljučni vazodilatatorji lahko močno poslabšajo kardiovaskularno stanje bolnikov s pljučno venookluzivno boleznijo.
• Follow carefully any instructions that come with the nebuliser.
• Skrbno upoštevajte navodila, ki so priložena nebulatorju.
• if you are at risk of bleeding- for example, if you have an active ulcer of the stomach or of the first part of the small intestine (duodenal ulcers), if you have suffered a physical injury (trauma), if you are at risk of bleeding within the skull,
• če pri vas obstaja tveganje za krvavitve - npr. če imate aktivno razjedo želodca ali začetnega dela tankega črevesa (duodenalni ulkus), če ste imeli telesno poškodbo (travmo) ali če pri vas obstaja tveganje za krvavitve znotraj lobanje,
Ask your doctor to have someone help you become thoroughly familiar with the use of the nebuliser.
Prosite zdravnika, da vam nekdo pomaga, dokler niste dovolj izkušeni z uporabo nebulatorja.
Do not change the recommended dose without consulting your doctor first.
Priporočenega odmerka ne spreminjajte brez predhodnega posveta z zdravnikom.
The pulmonary vasodilatory effect of each single inhalation levels off within one to two hours.
V pljučih vazodilatorni učinek vsake posamezne inhalacije izzveni v eni do dveh urah.
These alterations are not considered as teratogenic effects, but are most likely related to iloprost induced growth retardation in late organogenesis due to haemodynamic alterations in the foetoplacental unit.
Menijo, da pri teh spremembah ne gre za teratogene učinke, temveč so najverjetneje posledica z iloprostom povzročenega zastoja v rasti v obdobju pozne organogeneze zaradi hemodinamskih sprememb v placenti.
Very low levels of iloprost into milk were observed in rats (see section 5.3).
Pri podganah so opazili zelo nizke vrednosti iloprosta v mleku (glejte poglavje 5.3).
Ventavis is used to treat moderate cases of primary pulmonary hypertension (PPH) in adult patients.
Zdravilo Ventavis se uporablja za zdravljenje zmerne primarne pljučne hipertenzije (PPH) pri odraslih bolnikih.
• If you suffer from pulmonary hypertension, avoid getting pregnant as pregnancy may lead to a worsening of your condition and may even endanger your life.
• Če imate pljučno hipertenzijo, se izogibajte zanositvi, saj lahko nosečnost poslabša vašo bolezen ali celo ogrozi vaše življenje.
• If you experience difficulty breathing, cough up blood, and/or sweat excessively these may be signs that you have water in the lungs (lung oedema).
• Če imate težave pri dihanju, izkašljujete kri in/ali se zelo potite, so to lahko znaki tekočine v pljučih (pljučnega edema).
The occurrence of peripheral oedema can be related to the deterioration of the disease or insufficient effectiveness of the product.
Pojavljanje perifernega edema je lahko povezano z napredovanjem bolezni ali nezadostno učinkovitostjo zdravila.
If you have kidney or liver problems
Če imate okvaro ledvic ali jeter
Should signs of pulmonary oedema occur, the possibility of associated pulmonary veno-occlusive disease should be considered and treatment with Ventavis should be discontinued.
Če se pojavijo znaki pljučnega edema, je treba pomisliti na možnost pridružene pljučne venookluzivne bolezni in zdravljenje z zdravilom Ventavis prekiniti.
In subjects with normal renal and hepatic function, the disposition of iloprost following intravenous infusion is characterised in most cases by a two-phase profile with mean half-lives of 3 to 5 minutes and 15 to 30 minutes.
Pri osebah z normalnim ledvičnim in jetrnim delovanjem je po intravenskem infundiranju za porazdelitev iloprosta v večini primerov značilen dvofazni profil s povprečnimi razpolovnimi časi od 3 do 5 minut in od 15 do 30 minut.
− Cerebrovascular events (e.g. transient ischaemic attack, stroke) within the last 3 months.
- cerebrovaskularni dogodki (npr. prehodna možganska ishemija, kap) v zadnjih 3 mesecih
They should both have the same colour, either red for the 2.5 microgram dose or purple for the 5 microgram dose.
Oba morata biti iste barve, rdeča za 2,5-mikrogramski odmerek in vijolična za 5-mikrogramski odmerek.
Prolonged oral treatment with iloprost clathrate in dogs up to one year was associated with slightly increased fasted serum glucose levels.
Dolgotrajno (do enega leta trajajoče) peroralno zdravljenje z iloprost klatratom pri psih je bilo povezano z nekoliko povečanimi vrednostmi glukoze v serumu na tešče.
Symptoms can include swelling of feet and ankles, shortness of breath, palpitations, urinating more frequently at night or oedema.
Simptomi lahko vključujejo otekanje nog in gležnjev, kratko sapo, palpitacije, pogosto uriniranje ponoči ali otekanje.